Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to -$4.5 million.

  • Celularity's Change in Receivables rose 503.55% to -$4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.0 million, marking a year-over-year decrease of 13503.09%. This contributed to the annual value of $4.0 million for FY2024, which is 4187.78% down from last year.
  • Celularity's Change in Receivables amounted to -$4.5 million in Q3 2025, which was up 503.55% from -$3.8 million recorded in Q2 2025.
  • In the past 5 years, Celularity's Change in Receivables registered a high of $6.7 million during Q4 2023, and its lowest value of -$4.8 million during Q3 2024.
  • Moreover, its 5-year median value for Change in Receivables was $844000.0 (2021), whereas its average is $488684.2.
  • In the last 5 years, Celularity's Change in Receivables soared by 71764.71% in 2021 and then plummeted by 188333.33% in 2025.
  • Over the past 5 years, Celularity's Change in Receivables (Quarter) stood at $1.2 million in 2021, then fell by 22.42% to $896000.0 in 2022, then soared by 648.77% to $6.7 million in 2023, then decreased by 25.15% to $5.0 million in 2024, then crashed by 190.5% to -$4.5 million in 2025.
  • Its last three reported values are -$4.5 million in Q3 2025, -$3.8 million for Q2 2025, and $1.3 million during Q1 2025.